semaglutide vs insulin Ozempic : A Comparison Guide 2024 Is Ozempic® the Same as

Why semaglutide is getting attention

Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials

That said, long-term use comes with real considerations

At first, I couldnt tell much of a difference between the photos, but as I looked closer I definitely saw changes

The most common side effects were gastrointestinal, as expected with GLP-1 receptor agonist medications like Wegovy

Following high-profile reports in 2024 of an elevated risk of nonarteritic anterior ischemic optic neuropathy (NAION) in type 2 diabetes patients taking glucagonlike peptide-1 (GLP-1) receptor agonists seen at one facility (Massachusetts Eye and Ear), there remains a need to clarify the potential risk of ophthalmic complications from semaglutide exposure using multicenter data